Diversify Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Diversify Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$203K	Buy	+1,358	New	+$214K	﹤0.01%	1223

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.78% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

Diversify Advisory Services's XBI Position: Q3 2026 in Review

Diversify Advisory Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 1,358 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #1223 among its holdings.

217 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Diversify Advisory Services held 1,358 shares of State Street SPDR S&P Biotech ETF worth $203K as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Diversify Advisory Services position in Q3 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Diversify Advisory Services's portfolio in Q3 2026, its #1223 holding.
217 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Diversify Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.